BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 24857291)

  • 1. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles.
    Wang FB; Rong Y; Fang M; Yuan JP; Peng CW; Liu SP; Li Y
    Biomaterials; 2013 May; 34(15):3816-27. PubMed ID: 23465488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cell targeting using multiple aptamers conjugated on nanorods.
    Huang YF; Chang HT; Tan W
    Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging.
    Wang L; Li P; Xiao X; Li J; Li J; Yang HH; Tan W
    Talanta; 2018 Oct; 188():66-73. PubMed ID: 30029428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX.
    Shi H; Tang Z; Kim Y; Nie H; Huang YF; He X; Deng K; Wang K; Tan W
    Chem Asian J; 2010 Oct; 5(10):2209-13. PubMed ID: 20806314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells.
    Lee KY; Kang H; Ryu SH; Lee DS; Lee JH; Kim S
    J Biomed Biotechnol; 2010; 2010():168306. PubMed ID: 20204158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of liver cancer-specific aptamers using whole live cells.
    Shangguan D; Meng L; Cao ZC; Xiao Z; Fang X; Li Y; Cardona D; Witek RP; Liu C; Tan W
    Anal Chem; 2008 Feb; 80(3):721-8. PubMed ID: 18177018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex target SELEX.
    Shamah SM; Healy JM; Cload ST
    Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of aptamers for molecular recognition and characterization of cancer cells.
    Tang Z; Shangguan D; Wang K; Shi H; Sefah K; Mallikratchy P; Chen HW; Li Y; Tan W
    Anal Chem; 2007 Jul; 79(13):4900-7. PubMed ID: 17530817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using live cells to generate aptamers for cancer study.
    Meng L; Sefah K; Colon DL; Chen H; O'Donoghue M; Xiong X; Tan W
    Methods Mol Biol; 2010; 629():355-67. PubMed ID: 20387161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the target protein of the metastatic colorectal cancer-specific aptamer W3 as a biomarker by aptamer-based target cells sorting and functional characterization.
    Li W; Wu CC; Wang S; Zhou L; Qiao L; Ba W; Liu F; Zhan L; Chen H; Yu JS; Fang J
    Biosens Bioelectron; 2022 Oct; 213():114451. PubMed ID: 35700603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface.
    Ohuchi SP; Ohtsu T; Nakamura Y
    Biochimie; 2006 Jul; 88(7):897-904. PubMed ID: 16540230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-drug conjugation for targeted tumor cell therapy.
    Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
    Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro selection of DNA aptamers for metastatic breast cancer cell recognition and tissue imaging.
    Li X; Zhang W; Liu L; Zhu Z; Ouyang G; An Y; Zhao C; Yang CJ
    Anal Chem; 2014 Jul; 86(13):6596-603. PubMed ID: 24892693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selection and identification of DNA aptamers against DC-SIGN].
    Chen F; Zeng J; Sun P; Pan Q; Zhang XL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1133-6. PubMed ID: 19068192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers.
    Rong Y; Chen H; Zhou XF; Yin CQ; Wang BC; Peng CW; Liu SP; Wang FB
    Oncotarget; 2016 Feb; 7(7):8282-94. PubMed ID: 26882565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers targeting cell surface proteins.
    Takahashi M
    Biochimie; 2018 Feb; 145():63-72. PubMed ID: 29198584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and verification of ssDNA aptamers targeting human hepatocellular carcinoma.
    Lu B; Wang J; Zhang J; Zhang X; Yang D; Wu L; Luo Z; Ma Y; Zhang Q; Ma Y; Pei X; Yu H; Liu J
    Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):128-35. PubMed ID: 24300391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.